Fox Chase Cancer Center’s Joel Helmke Named Vice Chair of the Board of Directors of the Alliance of Dedicated Cancer Centers

Joel Helmke
Joel Helmke, MSHP, FACHE, chief operating officer of Fox Chase Cancer Center.

PHILADELPHIA (January 18, 2023)—Joel Helmke, MSHP, FACHE, chief operating officer of Fox Chase Cancer Center, has been named Vice Chair of the Board of Directors of the Alliance of Dedicated Cancer Centers (ADCC). The trade association represents 10 of the nation’s leading cancer hospitals, including Fox Chase.

“It is always a source of pride when any of our leaders, faculty, or staff members represents our institution on the national stage. Having worked at many of the nation’s best comprehensive cancer centers, Joel is a recognized national leader among cancer center administrators. His work with the ADCC is important in advocating for our brand of cancer care and in highlighting the work that we pursue so passionately,” said Robert Uzzo, MD, MBA, FACS, president and CEO of Fox Chase.

ADCC centers are at the forefront of developing best practices in cancer treatment and lead the way in driving new research about the causes, prevention, and diagnosis of cancer. The ADCC advocates before Congress and the administration on key issues impacting cancer hospitals and supports members in developing a narrative around the value that cancer hospitals provide to patients and the public.

In his leadership role with the ADCC, Helmke will advance progress toward the association’s priorities, which include protecting innovation in producing next-generation therapies, improving efficiencies in how cancer care is delivered, preserving quality-focused healthcare policies, and measuring and setting standards for cancer care quality to improve patient experience and clinical outcomes.

A particularly important effort for the ADCC is its Improving Goal Concordant Care (IGCC) Initiative. Through this collaborative project, ADCC institutions have embraced the vision that all patients with cancer and their families should receive care that aligns with their values and unique priorities.

Palliative care and oncology experts, together with patient and family advisors, are leading this initiative to address system gaps across ADCC member centers and to establish new expectations for when and how goals-of-care conversations occur with patients and their families.

“Joel joined Fox Chase in February 2021 from City of Hope National Medical Center in Duarte, California,” Uzzo said. “Already in his two years with us, he has demonstrated exceptional leadership in advancing our center through capital investment opportunities, technology enhancements, programmatic developments, and recruitment of additional talent.”

After a two-year term as ADCC Vice Chair, Helmke will advance to Chair of the ADCC Board of Directors.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427